HomeMarketsSharesCorbion N.V.

Trade Corbion N.V. - CORB CFD

Market is not available at the momentMarket information is presented
as of 2026-10-06T15:26:42+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.07
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
€1,000.00
Overnight funding adjustment
Charges from full value of position
-0.018016 %
(-€3.60)

Trade size with leverage ~ €20,000.00

Money from leverage ~ $€19,000.00


-0.01802%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
€1,000.00
Overnight funding adjustment
Charges from full value of position
-0.004207 %
(-€0.84)

Trade size with leverage ~ €20,000.00

Money from leverage ~ $€19,000.00


-0.00421%
Overnight funding adjustment time21:00 (UTC)
CurrencyEUR
Min traded quantity1
Margin5.00%
Stock exchangeNetherlands
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close21.455
Open21.575
1-Year Change30.21%
Day's Range21.475 - 22.055

Trade Corbion N.V. - CORB

About Corbion NV

Corbion NV is a company based in the Netherlands that is active in the field of biochemical ingredients. The Company's products include lactic acid derivatives, emulsifiers, functional enzyme blends, minerals and vitamins, among others. It operates through two business lines: Ingredient Solutions, divided into business segments Food and Biochemicals, as well as Innovation Platforms. The Food segment develops preservation ingredients and microbial spoilage prevention products for the baking, meat, dairy, confectionery and beverage industries, and the Biochemicals segment produces bio-based chemicals derived from renewable resources such as sugar or starch. The Innovation Platforms segment creates new biotechnology business platforms, such as the poly lactic acid (PLA) bioplastic or its algae ingredients business. The Company operates production sites in the United States, Brazil, Spain, the Netherlands and Thailand, and markets its products through a global network of retail offices.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Corbion NV revenues increased 9% to EUR1.07B. Net income increased 7% to EUR78.3M. Revenues reflect Sustainable Food Solutions segment increase of 7% to EUR584.2M, Lactic Acid and Specialties segment increase of 13% to EUR312.3M, Incubator segment increase from EUR13.4M to EUR30.7M, Asia segment increase of 13% to EUR193.8M, US segment increase of 4% to EUR499.2M.

Equity composition

04/2009, Stock Dividend, 1 new share for every 21 shares held.

Latest shares articles

Arm Holdings stock forecast
Arm Holdings stock forecast: Haas flags AI demand
Arm Holdings is a UK-based semiconductor company. Chief executive Rene Haas said AI and data-centre demand showed no signs of slowing. Explore third-party ARM price targets and technical analysis. Past performance is not a reliable indicator of future results.
9 hours ago
ENGIE stock forecast
ENGIE stock forecast: storage milestone, Euro Stoxx 50 entry
ENGIE is a French utility group. In September 2026, it confirmed global energy storage capacity above 10 gigawatts and is due to join the EURO STOXX 50. Explore third-party ENGI price targets and technical analysis. Past performance is not a reliable indicator of future results.
10 hours ago
A large Amazon logo displayed on the side of an Amazon building
Amazon stock forecast: FTC advertising lawsuit filed
Amazon is a US technology and retail company. In August 2026, the FTC and 22 states filed an advertising lawsuit against the group, which Amazon disputes. Explore third-party AMZN price targets and technical analysis. Past performance is not a reliable indicator of future results.
11 hours ago
BigBear.ai stock forecast
BigBear.ai stock forecast: backlog grows on new contracts
BigBear.ai reported Q2 2026 revenue of $36.7m, up 13% year over year, while backlog reached $269.6m after more than 20 new contracts. Explore third-party BBAI price targets and technical analysis. Past performance is not a reliable indicator of future results.
11 hours ago

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready